Epigenetics and Monoclonal histone modification antibodies

SYnAbs and Belgian Volition ink strategic agreement on epigenetics
SYnAbs enters in a strategic agreement with Volition to generate monoclonal antibodies against epigenetics biomarkers including modifications of histones and DNA, histone variants, and proteins associated with nucleosomes
Your DNA isn't your destiny: news on epigenetics
SYnAbs generates antibodies for epigenetic applications